Akinboboye O, Shah K, Warner AL, Damy et al (2020) DISCOVERY: prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosis. Amyloid. https://doi.org/10.1080/13506129.2020.1764928

Benson MD, Dasgupta NR, Rao R (2020) Diagnosis and screening of patients with hereditary transthyretin amyloidosis (hATTR): current strategies and guidelines. Ther Clin Risk Manag 16:749–758. https://doi.org/10.2147/TCRM.S185677

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown NA, Smith KC, Thornton RL (2015) Gathering perspectives on extended family influence on African American children’s physical activity. J Health Dispar Res Pract 8(1):10–24

PubMed  PubMed Central  Google Scholar 

Campbell-Salome G, Jones LK, Walters et al (2023) Optimizing communication strategies and designing a comprehensive program to facilitate cascade testing for familial hypercholesterolemia. BMC Health Serv Res. https://doi.org/10.1186/s12913-023-09304-y

Article  PubMed  PubMed Central  Google Scholar 

Chornokur G, Dalton K, Borysova ME, Kumar NB (2011) Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer. Prostate 71:985–997. https://doi.org/10.1002/pros.21314

Article  PubMed  Google Scholar 

Coelho T, Maurer MS (2016) THAOS - the transthyretin amyloidosis outcomes survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis. Curr Med Res Opin. https://doi.org/10.1185/03007995.2012.754348

Article  PubMed  Google Scholar 

den Heuvel Van, Lieke M, van Teijlingen MO et al (2020) Long-Term Follow-up Study on the Uptake of Genetic Counseling and Predictive DNA Testing in Inherited Cardiac Conditions. Circ Genom Precis Med 13(5):524–530

Article  PubMed  PubMed Central  Google Scholar 

Duran-Luciano P, Pandey A, Swett K (2025) Prevalence and phenotype of transthyretin Val122Ile variant in the Hispanic community health study/study of Latinos. JACC: Advances. https://doi.org/10.1016/j.jacadv.2025.102034

Article  PubMed  PubMed Central  Google Scholar 

Forrest LE, Burke J, Bacic S, Amor DJ (2008) Increased genetic counseling support improves communication of genetic information in families. Genet Med 10(3):167–172. https://doi.org/10.1038/ejhg.2015.174

Article  PubMed  Google Scholar 

Glenn BA, Chawla N, Bastani R (2012) Barriers to genetic testing for breast cancer risk among ethnic minority women: an exploratory study. Ethn Dis 22(3):267–273

PubMed  Google Scholar 

Grandis M, Obici L, Luigetti M et al (2020) Recommendations for pre-symptomatic genetic testing for hereditary transthyretin amyloidosis in the era of effective therapy: a multicenter Italian consensus. Orphanet J Rare Dis 15(1):348. https://doi.org/10.1186/s13023-020-01633-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hennink M, Hutter I, Bailey A (2020) Qualitative research methods, 2nd Ed. SAGE Publications

Google Scholar 

Kane C (2000). African American Family Dynamics as Perceived by Family Members. Journal of Black Studies 30(5). Sage Publications, Inc.

Mahfouz M, Maruyama R, Yokota T (2020) Inotersen for the Treatment of Hereditary Transthyretin Amyloidosis. Methods Mol Biol 2176:87–98. https://doi.org/10.1007/978-1-0716-0771-8_6

Article  CAS  PubMed  Google Scholar 

Maurer MS, Schwartz JH, Gundapaneni Bea et al (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 379(11):1007–1016. https://doi.org/10.1056/NEJMoa1805689

Article  CAS  PubMed  Google Scholar 

McCall MK, Connolly M, Nugent Bea et al (2020) Symptom experience, management, and outcomes according to race and social determinants including genomics, epigenomics, and metabolomics (SEMOARS + GEM): an explanatory model for breast cancer treatment disparity. J Cancer Educ 35(3):428–440. https://doi.org/10.1007/s13187-019-01571-w

Article  PubMed  PubMed Central  Google Scholar 

Miller DT, Lee K, Abul-Husn Nea et al (2022) ACMG SF v3.1 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG). Genet Med. https://doi.org/10.1016/j.gim.2022.04.006

Article  PubMed  PubMed Central  Google Scholar 

Nativi-Nicolau N, Maurer M (1978) Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness. Heart Fail Rev. https://doi.org/10.1007/s10741-021-10080-2

Article  Google Scholar 

Romagnoli KM, Kulchak Rahm A, Jonas MC et al (2023) Human-centered design study to inform traceback cascade genetic testing programs at three integrated health systems. Public Health Genom. https://doi.org/10.1159/000529852

Article  Google Scholar 

Rozenbaum MH, Large S, Bhambri Rea et al (2021) Impact of delayed diagnosis and misdiagnosis for patients with transthyretin amyloid cardiomyopathy (ATTR-CM): a targeted literature review. Cardiol Ther 10(1):141–159. https://doi.org/10.1007/s40119-021-00219-5

Article  PubMed  PubMed Central  Google Scholar 

Ruberg FL, Grogan M, Hanna M, Kelly JW, Maurer MS (2012) Transthyretin amyloid cardiomyopathy. J Am Coll Cardiol 73(22):2872–2891. https://doi.org/10.1016/j.jacc.2019.04.003

Article  CAS  Google Scholar 

Ruberg FL, Maurer MS, Judge Dea et al (2012) Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the transthyretin amyloidosis cardiac study (TRACS). Am Heart J 164(2):222–228. https://doi.org/10.1016/j.ahj.2012.04.015

Article  CAS  PubMed  Google Scholar 

Saulsberry K, Terry SF (2013) The need to build trust: a perspective on disparities in genetic testing. Genet Test Mol Biomarkers 17(9):647–648

Article  PubMed  PubMed Central  Google Scholar 

Shah LL, Daack-Hirsch S, Ersig Aea et al (2019) Family relationships associated with communication and testing for inherited cardiac conditions. West J Nurs Res 41(11):1576–1601. https://doi.org/10.1177/0193945918817039

Article  PubMed  Google Scholar 

Sher T, Velarde GP, Gertz MA (2020) V122I transthyretin cardiomyopathy. J Am Coll Cardiol 76(1):93–95. https://doi.org/10.1016/j.jacc.2020.04.074

Article  PubMed  Google Scholar 

Srinivasan S, Won NY, Dotson WD (2020) Barriers and facilitators for cascade testing in genetic conditions: a systematic review. Eur J Hum Genet. https://doi.org/10.1038/s41431-020-00725-5

Article  PubMed  PubMed Central  Google Scholar 

US Census 2020 Table 1: Educational Attainment of the Population 18 Years and Over, by Age, Sex, Race, and Hispanic Origin - Black Alone. https://www.census.gov/data/tables/2020/demo/educational-attainment/cps-detailed-tables.html. Accessed 25 November 2025.

Vera-Llonch M, Reddy SR, Chang E, Tarbox MH, Pollock M (2021) The patient journey toward a diagnosis of hereditary transthyretin (ATTRv) amyloidosis. Orphanet J Rare Dis 16(1):25–020. https://doi.org/10.1186/s13023-020-01623-1

Article  PubMed  PubMed Central  Google Scholar 

Weise N, Shaya J, Javier-Desloges J, Cheng HH, Madlensky L, McKay RR (2021) Disparities in germline testing among racial minorities with prostate cancer. Prostate Cancer Prostatic Dis 25(3):403–10. https://doi.org/10.1038/s41391-021-00469-3

Article  PubMed  PubMed Central  Google Scholar 

Yamashita T, Asl KH, Yazaki M, Benson MD (2005) A prospective evaluation of the transthyretin Ile122 allele frequency in an African-American population. Amyloid 12(2):127–130. https://doi.org/10.1080/13506120500107162

Article  CAS  PubMed  Google Scholar